Extensive efforts to battle cancer during the last few decades have resulted in overall cancer death rates declining. Major challenges still remain, however, in understanding, detecting, and treating this highly complex disease, and cancer continues to be a leading cause of death in the U.S. and worldwide.
Researchers and clinicians from Northwestern's International Institute for Nanotechnology and Robert H. Lurie Comprehensive Cancer Center have been working collaboratively since 2004 to bring the unique properties of nanotechnology to this effort.
Their substantial progress has resulted in the establishment of this (the third consequtive) CCNE funded by the National Cancer Institute.
Under the leadership of Professor Chad Mirkin and Dr. Leonidas Platanias, this Center is using nucleic acid-based nanoconstructs called Spherical Nucleic Acids (SNAs) to gain access to intracellular environments, discover new aspects of cancer biology, and create effective cancer treatment options for glioblastoma (brain cancer) and prostate cancer.
Sign up for our newsletter to receive information on events, news, and articles.